- 产品信息
商品描述
靶点-Target
PEG10
反应性
Human
应用
WB,IHC,IF,ELISA
宿主物种-Host Species
Mouse
修饰-Modification
Unmodified
MW(Calculated)
80kD
推荐稀释比
WB 1:500-1:2000;IHC 1:200-1:1000;IF 1:200-1:1000;ELISA 1:10000;Not yet tested in other applications.
组成
Liquid in PBS containing 50% glycerol, 0.5% BSA and 0.02% sodium azide.
纯化工艺
Affinity purification
储存
-15°C to -25°C/1 year(Do not lower than -25°C)
克隆性
Monoclonal
免疫原
Purified recombinant fragment of PEG10 (aa1-120) expressed in E. Coli.
特异性
PEG10 Monoclonal Antibody detects endogenous levels of PEG10 protein.
基因名称
PEG10
蛋白名称
Retrotransposon-derived protein PEG10
别名
PEG10;EDR;KIAA1051;MAR2;MART2;MEF3L1;RGAG3;Retrotransposon-derived protein PEG10;Embryonal carcinoma differentiation-regulated protein;Mammalian retrotransposon-derived protein 2;Myelin expression factor 3-like protein 1;MEF3-lik
Organism-1
Human
基因ID-1
23089
SwissProt-1
Q86TG7
Organism-2
Mouse
SwissProt-2
Q7TN75
背景
This is a paternally expressed imprinted gene that is thought to have been derived from the Ty3/Gypsy family of retrotransposons. It contains two overlapping open reading frames, RF1 and RF2, and expresses two proteins: a shorter, gag-like protein (with a CCHC-type zinc finger domain) from RF1; and a longer, gag/pol-like fusion protein (with an additional aspartic protease motif) from RF1/RF2 by -1 translational frameshifting (-1 FS). While -1 FS has been observed in RNA viruses and transposons in both prokaryotes and eukaryotes, this gene represents the first example of -1 FS in a eukaryotic cellular gene. This gene is highly conserved across mammalian species and retains the heptanucleotide (GGGAAAC) and pseudoknot elements required for -1 FS. It is expressed in adult and embryonic tissues (most notably in placenta) and reported to have a role in cell proliferation, differentiation and apoptosis.
细胞定位
Extracellular vesicle membrane . Cytoplasm . Nucleus . Forms virion-like extracellular vesicles that are released from cells (PubMed:34413232). Detected predominantly in the cytoplasm of breast and prostate carcinomas, in hepatocellular carcinoma (HCC) and B-cell chronic lymphocytic leukemia (B-CLL) cells and in the Hep-G2 cell line (PubMed:12810624). .





